Motif ID: Ascl2
Z-value: 0.707
Transcription factors associated with Ascl2:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Ascl2 | ENSMUSG00000009248.5 | Ascl2 |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 5.0 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 1.4 | 4.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) renal vesicle induction(GO:0072034) |
| 1.3 | 4.0 | GO:0072076 | hyaluranon cable assembly(GO:0036118) nephrogenic mesenchyme development(GO:0072076) negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 1.3 | 3.8 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
| 1.0 | 3.0 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
| 0.9 | 3.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.8 | 5.8 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.8 | 3.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) |
| 0.7 | 1.5 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.7 | 2.2 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
| 0.7 | 2.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.7 | 5.0 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.7 | 2.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.6 | 2.6 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
| 0.6 | 1.9 | GO:1903903 | striated muscle atrophy(GO:0014891) positive regulation of keratinocyte apoptotic process(GO:1902174) regulation of establishment of T cell polarity(GO:1903903) |
| 0.6 | 3.8 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.6 | 1.9 | GO:0042939 | renal sodium ion transport(GO:0003096) glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.6 | 3.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.6 | 1.7 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
| 0.5 | 1.6 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.5 | 2.5 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
| 0.5 | 2.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.5 | 2.8 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.5 | 1.9 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.5 | 1.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.5 | 3.2 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
| 0.5 | 1.4 | GO:0002586 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.5 | 1.8 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.4 | 1.3 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
| 0.4 | 2.6 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.4 | 2.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.4 | 1.2 | GO:0060166 | olfactory pit development(GO:0060166) |
| 0.4 | 8.9 | GO:0030903 | notochord development(GO:0030903) |
| 0.4 | 1.2 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
| 0.4 | 1.6 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
| 0.4 | 1.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.4 | 1.5 | GO:0010046 | arginine biosynthetic process(GO:0006526) response to mycotoxin(GO:0010046) |
| 0.4 | 0.4 | GO:0048389 | intermediate mesoderm development(GO:0048389) pattern specification involved in kidney development(GO:0061004) pattern specification involved in mesonephros development(GO:0061227) renal system pattern specification(GO:0072048) anterior/posterior pattern specification involved in kidney development(GO:0072098) ureter urothelium development(GO:0072190) |
| 0.4 | 4.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.4 | 2.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.3 | 1.0 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.3 | 4.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.3 | 3.8 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
| 0.3 | 2.4 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.3 | 1.0 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.3 | 4.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.3 | 2.6 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.3 | 1.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.3 | 4.4 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.3 | 4.0 | GO:0042711 | maternal behavior(GO:0042711) |
| 0.3 | 0.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.3 | 0.9 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.3 | 0.9 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.3 | 3.7 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.3 | 3.7 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.3 | 1.9 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
| 0.3 | 3.8 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.3 | 2.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.3 | 1.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.2 | 0.9 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.2 | 1.8 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.2 | 0.9 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.2 | 7.0 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 0.2 | 1.1 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.2 | 1.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.2 | 3.1 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.2 | 0.6 | GO:0040009 | nucleolus to nucleoplasm transport(GO:0032066) regulation of growth rate(GO:0040009) |
| 0.2 | 0.6 | GO:0046618 | drug export(GO:0046618) |
| 0.2 | 1.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.2 | 2.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.2 | 0.8 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.2 | 0.5 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
| 0.2 | 0.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.2 | 4.2 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.2 | 1.8 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.2 | 0.8 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.2 | 1.1 | GO:0061436 | establishment of skin barrier(GO:0061436) |
| 0.2 | 5.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.2 | 0.9 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.2 | 2.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
| 0.2 | 0.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.1 | 0.7 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.1 | 0.6 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.1 | 0.6 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.1 | 1.5 | GO:0009650 | UV protection(GO:0009650) |
| 0.1 | 0.7 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.1 | 0.4 | GO:0046959 | habituation(GO:0046959) |
| 0.1 | 0.4 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 | 0.7 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.1 | 6.1 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
| 0.1 | 0.4 | GO:0097278 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) complement-dependent cytotoxicity(GO:0097278) |
| 0.1 | 2.5 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 | 0.9 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 | 1.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 | 1.7 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 | 0.8 | GO:0006573 | valine metabolic process(GO:0006573) |
| 0.1 | 0.3 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
| 0.1 | 0.8 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.1 | 0.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.1 | 4.1 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
| 0.1 | 0.5 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.1 | 0.5 | GO:1903598 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) positive regulation of gap junction assembly(GO:1903598) |
| 0.1 | 0.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.1 | 0.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.1 | 0.3 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
| 0.1 | 0.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 1.4 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.1 | 0.8 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 1.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.1 | 1.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.1 | 0.7 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 | 0.7 | GO:0021678 | third ventricle development(GO:0021678) |
| 0.1 | 0.8 | GO:1904153 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 | 0.6 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
| 0.1 | 1.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 | 1.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 | 0.4 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.1 | 1.4 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
| 0.1 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.1 | 0.4 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.1 | 1.8 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 | 0.5 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 0.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 | 0.1 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.1 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.1 | 1.8 | GO:0001709 | cell fate determination(GO:0001709) |
| 0.1 | 0.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.1 | 0.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 | 3.2 | GO:0048663 | neuron fate commitment(GO:0048663) |
| 0.1 | 3.1 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.1 | 1.2 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.1 | 0.2 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.1 | 0.4 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.1 | 1.0 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 | 0.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.0 | 1.8 | GO:0006739 | NADP metabolic process(GO:0006739) |
| 0.0 | 0.1 | GO:0006706 | steroid catabolic process(GO:0006706) |
| 0.0 | 3.6 | GO:0046785 | microtubule polymerization(GO:0046785) |
| 0.0 | 0.5 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.0 | 1.3 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
| 0.0 | 1.1 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.0 | 1.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.0 | 1.0 | GO:0071320 | cellular response to cAMP(GO:0071320) |
| 0.0 | 0.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.0 | 2.0 | GO:1901998 | toxin transport(GO:1901998) |
| 0.0 | 1.6 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
| 0.0 | 1.3 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.0 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.0 | 0.2 | GO:0072061 | inner medullary collecting duct development(GO:0072061) regulation of nodal signaling pathway(GO:1900107) |
| 0.0 | 0.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.0 | 1.5 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 | 0.3 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
| 0.0 | 1.3 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
| 0.0 | 0.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 | 0.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
| 0.0 | 1.6 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.0 | 0.4 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.0 | 2.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.0 | 1.3 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 | 1.4 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
| 0.0 | 1.0 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
| 0.0 | 1.6 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
| 0.0 | 0.7 | GO:0045103 | intermediate filament-based process(GO:0045103) |
| 0.0 | 3.0 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
| 0.0 | 0.6 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.0 | 0.0 | GO:0072070 | loop of Henle development(GO:0072070) metanephric loop of Henle development(GO:0072236) |
| 0.0 | 0.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.0 | 1.4 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.0 | 0.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.0 | 0.3 | GO:0007602 | phototransduction(GO:0007602) |
| 0.0 | 0.6 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.0 | 0.5 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.0 | 0.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
| 0.0 | 0.5 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
| 0.0 | 0.6 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
| 0.0 | 0.5 | GO:2001222 | regulation of neuron migration(GO:2001222) |
| 0.0 | 1.4 | GO:0006959 | humoral immune response(GO:0006959) |
| 0.0 | 0.5 | GO:0009615 | response to virus(GO:0009615) |
| 0.0 | 0.6 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
| 0.0 | 0.3 | GO:0042407 | cristae formation(GO:0042407) |
| 0.0 | 0.1 | GO:0050855 | histone-threonine phosphorylation(GO:0035405) regulation of B cell receptor signaling pathway(GO:0050855) positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.0 | 0.2 | GO:0033292 | T-tubule organization(GO:0033292) |
| 0.0 | 0.7 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
| 0.0 | 0.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 | 0.3 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.0 | 0.9 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.0 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
| 0.0 | 1.2 | GO:0007030 | Golgi organization(GO:0007030) |
| 0.0 | 1.4 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
| 0.0 | 1.4 | GO:0008154 | actin polymerization or depolymerization(GO:0008154) |
| 0.0 | 1.6 | GO:0019827 | stem cell population maintenance(GO:0019827) |
| 0.0 | 0.6 | GO:0032526 | response to retinoic acid(GO:0032526) |
| 0.0 | 0.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.0 | 0.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.0 | 0.2 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.0 | 0.6 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.9 | 5.8 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
| 1.4 | 12.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.7 | 2.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.7 | 2.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.5 | 1.8 | GO:0043259 | laminin-1 complex(GO:0005606) laminin-10 complex(GO:0043259) |
| 0.4 | 2.5 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.4 | 1.9 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.4 | 1.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.4 | 5.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.3 | 1.4 | GO:0061702 | inflammasome complex(GO:0061702) |
| 0.3 | 2.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.3 | 2.1 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.3 | 1.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.2 | 1.2 | GO:1990357 | terminal web(GO:1990357) |
| 0.2 | 3.6 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.2 | 1.9 | GO:0030478 | actin cap(GO:0030478) |
| 0.2 | 0.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
| 0.2 | 1.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.2 | 1.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.2 | 3.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.2 | 1.8 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.1 | 1.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.1 | 1.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.1 | 0.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.1 | 6.3 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.1 | 0.7 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.1 | 0.6 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.1 | 0.2 | GO:0005816 | spindle pole body(GO:0005816) |
| 0.1 | 1.5 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.1 | 1.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 2.5 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 0.3 | GO:0005940 | septin ring(GO:0005940) |
| 0.1 | 0.9 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.1 | 0.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
| 0.1 | 0.3 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.1 | 1.1 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.1 | 4.4 | GO:0000791 | euchromatin(GO:0000791) |
| 0.1 | 1.2 | GO:0042555 | MCM complex(GO:0042555) |
| 0.1 | 1.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 0.5 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.1 | 5.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.1 | 1.8 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 0.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.1 | 0.6 | GO:0031970 | nuclear envelope lumen(GO:0005641) organelle envelope lumen(GO:0031970) |
| 0.1 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.1 | 1.7 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.1 | 0.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.1 | 0.9 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
| 0.0 | 1.7 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.0 | 19.9 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.0 | 1.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 0.8 | GO:0005605 | basal lamina(GO:0005605) |
| 0.0 | 2.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 2.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.0 | 1.0 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 0.4 | GO:0045095 | keratin filament(GO:0045095) |
| 0.0 | 0.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.0 | 0.1 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.0 | 2.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.0 | 1.2 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.0 | 0.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.0 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.0 | 0.3 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.0 | 1.9 | GO:0010008 | endosome membrane(GO:0010008) |
| 0.0 | 0.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.0 | 2.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.0 | 1.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 1.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 0.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 2.1 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.0 | 0.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.0 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.0 | 0.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.0 | 0.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.0 | 0.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 0.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.0 | 0.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 15.2 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 0.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.0 | 0.4 | GO:0016592 | mediator complex(GO:0016592) |
| 0.0 | 1.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.0 | 2.7 | GO:0005819 | spindle(GO:0005819) |
| 0.0 | 0.7 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 2.4 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 25.0 | GO:0070062 | extracellular exosome(GO:0070062) |
| 0.0 | 0.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.0 | 2.4 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.0 | 1.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.0 | 0.4 | GO:0030496 | midbody(GO:0030496) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.5 | 4.4 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 1.0 | 3.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.9 | 4.7 | GO:0018121 | imidazoleglycerol-phosphate synthase activity(GO:0000107) NAD(P)-cysteine ADP-ribosyltransferase activity(GO:0018071) NAD(P)-asparagine ADP-ribosyltransferase activity(GO:0018121) NAD(P)-serine ADP-ribosyltransferase activity(GO:0018127) 7-cyano-7-deazaguanine tRNA-ribosyltransferase activity(GO:0043867) purine deoxyribosyltransferase activity(GO:0044102) |
| 0.8 | 0.8 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.7 | 2.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.7 | 2.1 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.6 | 1.8 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
| 0.5 | 1.6 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.5 | 5.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.5 | 1.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.4 | 2.5 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.4 | 3.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.4 | 1.5 | GO:0004096 | aminoacylase activity(GO:0004046) catalase activity(GO:0004096) |
| 0.4 | 4.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.4 | 3.3 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.3 | 1.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
| 0.3 | 3.4 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
| 0.3 | 1.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.3 | 4.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.3 | 7.4 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
| 0.3 | 0.9 | GO:0005534 | galactose binding(GO:0005534) |
| 0.3 | 0.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.3 | 2.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.3 | 1.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.2 | 1.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.2 | 0.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.2 | 1.2 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
| 0.2 | 1.9 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
| 0.2 | 2.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.2 | 0.9 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
| 0.2 | 1.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.2 | 1.1 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.2 | 9.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.2 | 2.2 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
| 0.2 | 1.9 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.2 | 2.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.2 | 5.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.2 | 4.3 | GO:0035380 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
| 0.2 | 0.9 | GO:0044020 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.2 | 1.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.2 | 0.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.2 | 5.0 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
| 0.2 | 14.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.2 | 1.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.2 | 0.8 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.2 | 1.5 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.2 | 1.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.2 | 0.9 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
| 0.2 | 1.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.2 | 0.8 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 0.6 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.1 | 1.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.1 | 0.6 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
| 0.1 | 1.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.1 | 0.6 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.1 | 0.4 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.1 | 1.8 | GO:0015197 | peptide transporter activity(GO:0015197) |
| 0.1 | 1.3 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.1 | 0.6 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.1 | 0.5 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 0.1 | 0.9 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.1 | 0.8 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
| 0.1 | 1.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
| 0.1 | 2.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.1 | 10.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.1 | 0.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.1 | 4.0 | GO:0070888 | E-box binding(GO:0070888) |
| 0.1 | 1.2 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.1 | 2.2 | GO:0043394 | proteoglycan binding(GO:0043394) |
| 0.1 | 0.4 | GO:2001070 | starch binding(GO:2001070) |
| 0.1 | 1.0 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
| 0.1 | 1.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.1 | 3.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 0.2 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.1 | 0.6 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.1 | 0.9 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 3.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.1 | 2.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.1 | 0.4 | GO:0002135 | CTP binding(GO:0002135) |
| 0.1 | 1.6 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.1 | 1.9 | GO:0005112 | Notch binding(GO:0005112) |
| 0.1 | 1.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.1 | 0.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.1 | 1.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 0.7 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 0.1 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
| 0.1 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) uridylate kinase activity(GO:0009041) |
| 0.1 | 0.5 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
| 0.1 | 0.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.0 | 0.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.0 | 1.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.0 | 9.5 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 0.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.0 | 0.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.0 | 1.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.0 | 0.0 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.0 | 0.4 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.0 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.0 | 3.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.0 | 0.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.0 | 0.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.0 | 0.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.0 | 0.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.0 | 0.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.0 | 2.2 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.0 | 2.1 | GO:0015108 | chloride transmembrane transporter activity(GO:0015108) |
| 0.0 | 1.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.0 | 1.2 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.0 | 0.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.0 | 0.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.0 | 3.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 0.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.0 | 1.6 | GO:0051287 | NAD binding(GO:0051287) |
| 0.0 | 2.0 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.0 | 0.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.0 | 1.0 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.0 | 5.3 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
| 0.0 | 2.0 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.0 | 0.5 | GO:0044653 | trehalase activity(GO:0015927) dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
| 0.0 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.0 | 1.6 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
| 0.0 | 0.7 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.0 | 1.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.0 | 0.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.0 | 0.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.0 | 0.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.0 | 1.3 | GO:0019210 | protein kinase inhibitor activity(GO:0004860) kinase inhibitor activity(GO:0019210) |
| 0.0 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.0 | 0.9 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.0 | 3.5 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
| 0.0 | 5.3 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.0 | 0.7 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.0 | 5.3 | GO:0003779 | actin binding(GO:0003779) |
| 0.0 | 0.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.0 | 0.3 | GO:0004672 | protein kinase activity(GO:0004672) |
| 0.0 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 0.0 | 0.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.0 | 1.1 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
